Published in Telemedicine Law Weekly, January 30th, 2010
"No reports have described their utility in cutaneous GVHD or the ability of leukocyte scintigraphy to evaluate treatment response at any site. This case shows significant radiolabeled leukocyte uptake in a man with extensive cutaneous GVHD, with subsequent near complete resolution after therapy," wrote E. Mittra and colleagues, Stanford University.
The researchers concluded: "As such, leukocyte scintigraphy may provide an alternate way to assess the burden of GVHD and response to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Telemedicine Law Weekly